Through their subsidiary of PT Global Onkolab Farma, PT Kalbe Farma Tbk (Kalbe) collaborates withPrimayaHospitalGroup to strengthen centralized services in treating cancer cases in Indonesia. This collaboration is marked by the signing of a memorandum of understanding by the Director of PT Kalbe Farma Tbk, Mulialie and the CEO of PrimayaHospitalGroupLeona A. Karnali.
“We are happy to partner with PrimayaHospitalGroup with their comprehensive cancer-treatment services. We hope this strategic collaboration can bring about the best and the most optimum treatment experience for patients. Through more sophisticated healthcare services and the larger availability of drugs, especially good cancer drugs, we hope that we can reach out to various layers of the Indonesian society,” says the Director of PT Kalbe Farma Tbk, Mulialie.
“PusatLayananKanker (Cancer Treatment Centre) is one of Primaya Hospital’s highlighted services. Primaya Hospital provides comprehensive services and facilities starting from cancer detection, surgery, and chemotherapies to immunotherapies. We can handle all types of cancer both in adults and in children. Besides focusing on cancer treatment, we also maintain the life quality of our patients that it can stay the same during the treatment process. Through our collaboration with Kalbe, we hope that people will find it easier to get healthcare services, especially for those with cancer. With our good services and facilities, we are optimistic that we can help the people so that they would not have to go the distance to overseas, because now, at Primaya Hospital Group, those services and facilities are available,” says the CEO of PrimayaHospitalGroup,Leona A. Karnali.
The collaboration between PrimayaHospitalGroup and Kalbe Farma Group is on a long-term basis and has a wide scope. This collaboration can support the services of Primaya Hospital Group’s Oncology Center in treating complex cancer cases to improve diagnostics and therapeutical services. Therefore, these services can minimize late treatments of cancer, improve the efficacy of cancer therapies that use specific methods, expand the opportunity for all Indonesians to get equitable access and services to healthcare, and support the independence of local healthcare services, especially in cancer treatment.
This collaboration encourages PrimayaHospitalGroup in providing additional values for their Oncology Center services, like in the provision and development of various chemotherapy drugs and radiotherapy services by preparing the provision of radiofarmaka to support future PET-CT services; and other cancer-related services like nutritional products for cancer treatment. Global Onkolab Farma is one of the first cancer drugs manufacturers that specialize in local manufacturing of high-quality affordable oncology products by utilizing advanced technology.
Global Onkolab Farma at a Glance
PT Global Onkolab Farma is one of the subsidiaries of PT Kalbe Farma that focuses on the development and creation of various kinds of cancer medicines, including prescription-based drugs, therapies, and supporting regimens.
Operating in Indonesia, this company is one of the first cancer drugs manufacturers that specialize in local manufacturing of high-quality affordable oncology products by utilizing advanced technology.
To serve cancer patients better, PT Global Onkolab Farma is committed in developing more effective cancer drugs and other cancer-related services, such as nutritional products and by collaborating with nearby cancer communities to provide support systems for cancer patients.
Kalbe at a Glance
PT Kalbe Farma Tbk (Kalbe) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle a portfolio of dependable and various brands: the prescription pharmaceutical division, the health products division that handles over-the-counter drugs, multivitamins, and ready-to-serve supplemental drinks, the nutritions division, and the distribution & logistics division.
Kalbe has also developed B2B-based digital services ecosystems for the society: EMOS and MOSTRANS. EMOS is an order management application system that helps distribution channels perform their stock or supply chain management actions. MOSTRANS is a B2B transportation solution provider for the easy management and the efficiency of transportation.
Kalbe now has more than 40 subsidiaries and 14 international-standard production facilities, supported by around 16,000 employees in 71 branches throughout Indonesia. Kalbe’s shares have been listed in Indonesia Stock Exchange/Bursa Efek Indonesia (IDX:KLBF) since 1991. For more information, please visit https://www.kalbe.co.id/
Primaya Hospital Group at a Glance
PrimayaHospital is a hospital with the values of PRIMA – Profesional (Professional),Rapi (Orderly),Ibadah (Service),Mendengarkan (Listening), andAsertif (Assertive) – that prioritizes patients’ well-being. We provide comprehensive healthcare services for all of Indonesians and foreigners (WNA) through the use of adequate technologies and by providing services for patients that are covered by various companies, insurances, BPJS, and private funds. To reach out to the needs of the society, Primaya Hospital has 15 networks of hospitals that are spread in various big cities in Indonesia, such as Jakarta, Bekasi, Tangerang,Depok, Semarang, Sukabumi, Makasar, Palangkaraya, and Pangkal Pinang. Some of the highlights in our services that we provide for our patients are: our Heart and Vascular Center, Mother and Child Center, Sports Clinic & Orthopedic Center, Cancer Center, Diabetes Center, Urology Center, Geriatric Center, Eye Center, and others. Primaya Hospital offers comprehensive service facilities like Emergency, Radiology, Laboratory, and Pharmacy services that are open 24/7. We also have spacious parking areas, rooms for patients education, comfortable clinics, lactation rooms, ATM Centers, Prayer Rooms, Wi-Fi connection for patients’ families, canteens, and other cozy facilities.